Harmony Biosciences 8-K Report: Key Updates You Can't Miss!
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: Harmony Biosciences Holdings, Inc.
- State of Incorporation: Delaware (DE)
- CIK Number: 0001802665
- Business Address: 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA 19462
- Contact Number: 484-539-9800
- Filing Details:
- Form Type: 8-K (Current Report)
- Filing Date: January 13, 2025
- Stock Information:
- Common Stock Par Value: $0.00001 per share
- Stock Ticker: HRMY
- Exchange: NASDAQ
- Period of Reporting:
- Start Date: January 13, 2025
- End Date: January 13, 2025
- Additional Notes:
- The filing appears to be a current report (8-K) which is typically used by public companies to disclose major events that shareholders should know about.
Insights:
- The filing date aligns with a specific event on the same day, suggesting that the company is reporting an important update or occurrence.
- The company operates in the biotechnology sector, indicated by its name and likely focus area, which can be relevant for investors tracking developments in healthcare and pharmaceuticals.
- The low par value of the common stock may indicate a growth-oriented or startup company, common in the biotech industry where companies often have minimal initial capital.
- Investors should monitor this 8-K filing for any significant news regarding the company’s operations, financial performance, or other material events that could impact stock performance.